Subjective and objective measurement of human accommodative amplitude
Jon E. Wold, OD, Annie Hu, OD, Stephanie Chen, OD, Adrian Glasser, PhD

1. What is the most widely used clinical method of assessing accommodative amplitude?
a. Focometer
b. Badal optometer
c. Push-up test
d. Hastinger coincidence refractometer

2. Which method of measuring accommodative amplitude is ideally suited to measure a small pupil?
a. In-focus focometer
b. Badal optomoeter
c. Push-up test
d. Hartinger coincidence refractometer

3. According to the article, when stimulated by trial-lens-induced blur and measured with the Hartinger refractometer, the accommodation in most subjects measured from
a. 3.0 to 6.0 D
b. 6.0 to 8.0 D
c. 8.0 to 12.0 D
d. 5.0 to 10.0 D

Laser in situ keratomileusis correction of mixed astigmatism by bitoric ablation
Mohamed A. Hassaballa, MD, FRCSEd, Maria Jose Ayala, MD, PhD, Jorge L. Alio, MD, PhD

4. According to the article, in patients with mixed astigmatism, the best results were obtained using
a. Bitoric ablation
b. Monotoric ablation
c. Either type of ablation
d. Negative-cylinder ablation

5. What was the mean reduction in the magnitude of cylinder using bitoric ablation?
a. 1.50 D
b. 1.82 D
c. 3.29 D
d. 3.75D

6. What was the mean cylinder reduction in the monotoric group at 6 months?
a. 1.50 D
b. 1.82 D
c. 2.53 D
d. 3.75 D

Adusting intraocular lens power for sulcus fixation
Chikako Suto, MD, Sadao Hori, MD, Eriko Fukuyama, MD, Junsuke Akura, MD

7. As concluded by the article, for sulcus fixation in eyes with a normal axial length, the IOL power should be:
a. 0.5 D less than the power for the in-the-bag fixation
b. 1.0 D less than the power for the in-the-bag fixation
c. 1.5 D less than the power for the in-the-bag fixation
d. 1.75 D less than the power for the in-the-bag fixation

8. What myopic shift from the predicted refraction occurred after sulcus fixation?
a. 0.95 +/- 0.05 D
b. 0.78 +/- 0.47 D
c. 0.75 +/- 0.53 D
d. 1.5 +/- 0.47 D

9. What was the correction of the lens power for sulcus fixation of high-powered lenses?
a. 1.00 to 1.50 D reduction in power
b. 1.50 to 2.00 D reduction in power
c. 0.50 reduction in power
d. 1.25 to 1.50 D reduction in power

Ultrasound biomicroscopy of silicone posterior chamber phakic intraocular lens for myopia
Julian Garcia-Feijoo, MD, PhD, Jose L. Hernandez-Matamoros, MD, Carmen Mendez-Hernandez, MD, Alfredo Castillo-Gomez, MD, Carlos Lazaro, MD, PhD, Teresa Martin, MD, Ricardo Cuina-Sardina, MD, Julian Garcia-Sanchez, MD, PhD

10. According to the article, what is the theoretical advantage of correction of high myopia by phakic IOLs?
a. Excellent refractive results
b. Preservation of accommodation
c. Reversibility
d. All the above

11. What is the long-term risk of posterior chamber phakic IOL implantation in patients with high myopia?
a. Retinal detachment
b. Chronic granulomatosis uveitis
c. Pigment dispersion syndrome
d. Ciliary body detachment

12. What is the best method of assessing the position of phakic IOL in the living eye?
a. UBM (ultrasound biomicroscopy)b. Gonioscopy
c. Slit-lamp examination
d. B-scan

Clorazepate dipotassium versus midazolam for premedication in clear corneal cataract surgery
Thomas Laube, MD, Hyunil Krohner, MD, Gabriele Helga Franke, PhD, Claudia Brockmann, Klaus-Peter Steuhl, MD

13. According to the article, intravenous midazolam was superior to oral clorazepate dipotassium in achieving
a. Patient cooperation
b. Fewer complications during surgery
c. The level of anterograde amnesia
d. Patient satisfaction scores

14. One day postoperatively
a. Visual acuity in the midazolam group was significantly better than in the clorazepate dipotassium group.
b. Visual acuity in the clorazepate dipotassium group was much better than in the midazolam group.
c. There was no difference in visual acuity in the midazolam group versus the clorazepate dipotassium group.
d. Visual acuity in the midazolam group was significantly better than in the topical anesthesia group.

15. The level of postoperative anxiety was less with
a. Clorazepate dipotassium
b. Midazolam
c. Topical anesthetic
d. Sub-Tenon’s anesthesia